Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion

Detalles Bibliográficos
Autores principales: Velloso, Elvira Deolinda Rodrigues Pereira, Magalhães, Silvia Maria Meira, Chauffaille, Maria de Lourdes Lopes Ferrari, Buzzini, Renata, Bernardo, Wanderley Marques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2018
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098188/
https://www.ncbi.nlm.nih.gov/pubmed/30128437
http://dx.doi.org/10.1016/j.htct.2018.05.011
_version_ 1783348423149223936
author Velloso, Elvira Deolinda Rodrigues Pereira
Magalhães, Silvia Maria Meira
Chauffaille, Maria de Lourdes Lopes Ferrari
Buzzini, Renata
Bernardo, Wanderley Marques
author_facet Velloso, Elvira Deolinda Rodrigues Pereira
Magalhães, Silvia Maria Meira
Chauffaille, Maria de Lourdes Lopes Ferrari
Buzzini, Renata
Bernardo, Wanderley Marques
author_sort Velloso, Elvira Deolinda Rodrigues Pereira
collection PubMed
description
format Online
Article
Text
id pubmed-6098188
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-60981882018-08-20 Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion Velloso, Elvira Deolinda Rodrigues Pereira Magalhães, Silvia Maria Meira Chauffaille, Maria de Lourdes Lopes Ferrari Buzzini, Renata Bernardo, Wanderley Marques Hematol Transfus Cell Ther Guideline Sociedade Brasileira de Hematologia e Hemoterapia 2018 2018-07-27 /pmc/articles/PMC6098188/ /pubmed/30128437 http://dx.doi.org/10.1016/j.htct.2018.05.011 Text en © 2018 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Guideline
Velloso, Elvira Deolinda Rodrigues Pereira
Magalhães, Silvia Maria Meira
Chauffaille, Maria de Lourdes Lopes Ferrari
Buzzini, Renata
Bernardo, Wanderley Marques
Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
title Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
title_full Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
title_fullStr Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
title_full_unstemmed Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
title_short Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
title_sort part 3: myelodysplastic syndromes—treatment of low-risk patients without the 5q deletion
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098188/
https://www.ncbi.nlm.nih.gov/pubmed/30128437
http://dx.doi.org/10.1016/j.htct.2018.05.011
work_keys_str_mv AT vellosoelviradeolindarodriguespereira part3myelodysplasticsyndromestreatmentoflowriskpatientswithoutthe5qdeletion
AT magalhaessilviamariameira part3myelodysplasticsyndromestreatmentoflowriskpatientswithoutthe5qdeletion
AT chauffaillemariadelourdeslopesferrari part3myelodysplasticsyndromestreatmentoflowriskpatientswithoutthe5qdeletion
AT buzzinirenata part3myelodysplasticsyndromestreatmentoflowriskpatientswithoutthe5qdeletion
AT bernardowanderleymarques part3myelodysplasticsyndromestreatmentoflowriskpatientswithoutthe5qdeletion

Ejemplares similares